This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...
New research at MSU uses light to reveal viruses’ unique vibrations, opening new doors for biological imaging and antiviral ...
UConn researchers have identified a novel small molecule for the development of a preventative treatment for a serious and ...
New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb ...
UroGen Pharma has broadened its oncology pipeline by acquiring IconOVir Bio’s assets related to the oncolytic virus ICVB-1042 ...
Northwestern University researchers have identified structural features in engineered cell receptors that correlate with ...
New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...
UroGen Pharma has opened another front in its attack on bladder cancer, paying IconOVir Bio $4 million in stock for an early-phase oncolytic virus that could work like a turbocharged Bacillus Calmette ...
The cell and gene therapies in rare disorders market is expected to grow at a significantly high rate during the forecast period (2025–2034) and main ...